Biopharmaceutical Committee
The Biopharmaceutical Committee makes policy recommendations on the development of infrastructure for the promotion of biopharmaceutical research and development. The committee also conducts surveys and research on various technical issues related to biopharmaceuticals, from research and development to production and post-marketing activities, and makes recommendations for improvement to the government and other relevant agencies.
Announcements and Updates
-
Biopharmaceutical Committee
Report on "BioJapan 2025" and its participation
-
Biopharmaceutical Committee
Report on the "Pharmaceutical Cooperative Media Forum" is now available.
-
Biopharmaceutical Committee
The report of "BioJapan 2025" was published in the "Pharmaceutical Association of Japan (PAK) Media Forum".
-
Biopharmaceutical Committee
The report "Analysis of Application Documents for Regenerative Medicine Product Approval (Life Cycle Management Information)" is updated.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2024" is now available.
Biopharmaceuticals Committee Contents
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Biopharmaceuticals
The importance and diversity of biopharmaceuticals, which are indispensable and valuable for modern medicine, are explained in an easy-to-understand manner.
-
Deliverables of the Biopharmaceuticals Committee
The Biopharmaceuticals Committee's deliverables are posted.
-
Information from Biopharmaceuticals Committee
Various announcements from the Biopharmaceuticals Committee are posted.